SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/13 – ‘R9’

On:  Monday, 3/17/14, at 4:22pm ET   ·   For:  12/31/13   ·   Accession #:  1564590-14-856   ·   File #:  0-19627

Previous ‘10-K’:  ‘10-K’ on 3/15/13 for 12/31/12   ·   Next:  ‘10-K/A’ on 4/30/14 for 12/31/13   ·   Latest:  ‘10-K’ on 3/21/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/17/14  Biolase, Inc                      10-K       12/31/13   76:14M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.28M 
 2: EX-4        Ex-4.4                                              HTML     29K 
 3: EX-10       Ex-10.42                                            HTML     61K 
 4: EX-21       Ex-21.1                                             HTML     21K 
 5: EX-23       Ex-23.1                                             HTML     23K 
 6: EX-31       Ex-31.1                                             HTML     29K 
 7: EX-31       Ex-31.2                                             HTML     29K 
 8: EX-32       Ex-32.1                                             HTML     25K 
 9: EX-32       Ex-32.2                                             HTML     25K 
53: R1          Document and Entity Information                     HTML     53K 
43: R2          Consolidated Balance Sheets                         HTML    144K 
51: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
55: R4          Consolidated Statements Of Operations And           HTML    107K 
                Comprehensive Loss                                               
71: R5          Consolidated Statements Of Shareholders' Equity     HTML    101K 
                (Deficit)                                                        
45: R6          Consolidated Statements Of Cash Flows               HTML    176K 
50: R7          Basis of Presentation                               HTML     55K 
39: R8          Summary of Significant Accounting Policies          HTML    152K 
30: R9          Supplementary Balance Sheet Information             HTML    122K 
72: R10         Intangible Assets and Goodwill                      HTML     92K 
57: R11         Lines of Credit and Other Borrowings                HTML     44K 
56: R12         Income Taxes                                        HTML    190K 
62: R13         Commitments and Contingencies                       HTML     56K 
63: R14         Stockholders' Equity                                HTML    274K 
61: R15         Segment Information                                 HTML     49K 
64: R16         Concentrations                                      HTML     26K 
52: R17         Subsequent Events                                   HTML     38K 
54: R18         Schedule II-Consolidated Valuation and Qualifying   HTML     88K 
                Accounts and Reserves                                            
60: R19         Accounting Policies (Policies)                      HTML    306K 
76: R20         Summary of Significant Accounting Policies          HTML    109K 
                (Tables)                                                         
67: R21         Supplementary Balance Sheet Information (Tables)    HTML    129K 
47: R22         Intangible Assets and Goodwill (Tables)             HTML     83K 
58: R23         Income Taxes (Tables)                               HTML    183K 
49: R24         Commitments and Contingencies (Tables)              HTML     31K 
24: R25         Stockholders' Equity (Tables)                       HTML    229K 
68: R26         Segment Information (Tables)                        HTML     41K 
73: R27         Basis of Presentation - Additional Information      HTML     52K 
                (Detail)                                                         
34: R28         Estimated Useful Lives of Property, Plant and       HTML     28K 
                Equipment (Detail)                                               
33: R29         Changes in Initial Product Warranty Accrual and     HTML     41K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
37: R30         Classification of Compensation Expense Associated   HTML     32K 
                with Share-Based Payments (Detail)                               
38: R31         Assumptions Used in Estimating Fair Value of Stock  HTML     35K 
                Options Granted (Detail)                                         
40: R32         Summary of Significant Accounting Policies -        HTML     57K 
                Additional Information (Detail)                                  
22: R33         Components of Accounts Receivable, Net of           HTML     31K 
                Allowance (Detail)                                               
65: R34         Components of Inventory (Detail)                    HTML     34K 
46: R35         Summary of Property, Plant, and Equipment (Detail)  HTML     45K 
48: R36         Components of Accrued Liabilities (Detail)          HTML     51K 
27: R37         Summary of Deferred Revenue (Detail)                HTML     40K 
75: R38         Supplementary Balance Sheet Information -           HTML     48K 
                Additional Information (Detail)                                  
16: R39         Intangible Assets and Related Accumulated           HTML     56K 
                Amortization (Detail)                                            
41: R40         Intangible Assets and Goodwill - Additional         HTML     44K 
                Information (Detail)                                             
70: R41         Lines of Credit and Other Borrowings - Additional   HTML    137K 
                Information (Detail)                                             
26: R42         Summary of Income Tax Current and Deferred          HTML     69K 
                Provision (Benefit) (Detail)                                     
32: R43         Federal Income Tax Provision Compared With          HTML     63K 
                Statutory Rates (Detail)                                         
36: R44         Summary of Net Deferred Tax Assets and Net          HTML     87K 
                Deferred Tax Liabilities (Detail)                                
44: R45         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
21: R46         Income Taxes - Additional Information (Detail)      HTML     58K 
29: R47         Commitments and Contingencies - Additional          HTML     41K 
                Information (Detail)                                             
18: R48         Future Minimum Rental Commitments Under Operating   HTML     45K 
                Lease Agreements (Detail)                                        
69: R49         Summary of Option Activity (Detail)                 HTML     81K 
25: R50         Options Outstanding and Exercisable (Detail)        HTML     70K 
66: R51         Cash Proceeds Along with Fair Value Disclosures     HTML     41K 
                Related to Grants Exercises and Vesting Options                  
                (Detail)                                                         
28: R52         Stockholders' Equity - Additional Information       HTML    251K 
                (Detail)                                                         
42: R53         Summary of Net Revenue by Geographic Location       HTML     27K 
                (Detail)                                                         
17: R54         Segment Information - Additional Information        HTML     32K 
                (Detail)                                                         
20: R55         Concentrations - Additional Information (Detail)    HTML     36K 
35: R56         Subsequent Events - Additional Information          HTML     67K 
                (Detail)                                                         
23: R57         Consolidated Valuation and Qualifying Accounts and  HTML     36K 
                Reserves (Detail)                                                
74: XML         IDEA XML File -- Filing Summary                      XML    111K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX    190K 
31: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.05M 
10: EX-101.INS  XBRL Instance -- biol-20131231                       XML   2.69M 
12: EX-101.CAL  XBRL Calculations -- biol-20131231_cal               XML    200K 
13: EX-101.DEF  XBRL Definitions -- biol-20131231_def                XML   1.08M 
14: EX-101.LAB  XBRL Labels -- biol-20131231_lab                     XML   1.53M 
15: EX-101.PRE  XBRL Presentations -- biol-20131231_pre              XML   1.21M 
11: EX-101.SCH  XBRL Schema -- biol-20131231                         XSD    220K 
59: ZIP         XBRL Zipped Folder -- 0001564590-14-000856-xbrl      Zip    215K

‘R9’   —   Supplementary Balance Sheet Information

This is an IDEA Financial Report.  [ Alternative Formats ]

 
v2.4.0.8
Supplementary Balance Sheet Information
 12 Months Ended
Supplemental Balance Sheet Disclosures

NOTE 3 — SUPPLEMENTARY BALANCE SHEET INFORMATION

 

 

 

December 31,

 

ACCOUNTS RECEIVABLE (in thousands):

 

2013

 

 

2012

 

Components of accounts receivable, net of allowances, are as follows:

 

 

 

 

 

 

 

 

Trade

 

$

10,960

 

 

$

11,456

 

Royalties

 

 

82

 

 

 

45

 

Other

 

 

85

 

 

 

179

 

Total receivables, net

 

$

11,127

 

 

$

11,680

 

Accounts receivable is net of allowances for doubtful accounts of approximately $573,000 and $304,000 and sales returns of approximately $110,000 and $110,000 at December 31, 2013 and 2012, respectively.

 

 

 

December 31,

 

INVENTORY, NET (in thousands):

 

2013

 

 

2012

 

Components of inventory, net of allowances, are as follows:

 

 

 

 

 

 

 

 

Raw materials

 

$

3,094

 

 

$

4,017

 

Work-in-process

 

 

1,727

 

 

 

1,949

 

Finished goods

 

 

6,557

 

 

 

5,176

 

Inventory, net

 

$

11,378

 

 

$

11,142

 

Inventory is net of a provision for excess and obsolete inventory totaling approximately $2.8 million and $1.9 million at December 31, 2013 and 2012, respectively.

 

 

 

December 31,

 

PROPERTY, PLANT, AND EQUIPMENT, NET (in thousands):

 

2013

 

 

2012

 

Components of property, plant, and equipment, net of depreciation, are as follows:

 

 

 

 

 

 

 

 

Building

 

$

256

 

 

$

246

 

Leasehold improvements

 

 

1,207

 

 

 

1,193

 

Equipment and computers

 

 

6,078

 

 

 

5,219

 

Furniture and fixtures

 

 

1,049

 

 

 

1,046

 

Construction in progress

 

 

8

 

 

 

132

 

 

 

 

8,598

 

 

 

7,836

 

Accumulated depreciation and amortization

 

 

(6,971

)

 

 

(6,518

)

 

 

 

1,627

 

 

 

1,318

 

Land

 

 

199

 

 

 

191

 

Property, plant, and equipment, net

 

$

1,826

 

 

$

1,509

 

On August 21, 2012, pursuant to a Sale and Purchase Agreement entered on June 12, 2012, the Company sold the smaller of two buildings and a portion of the land parcel of its two-building property in Floss, Germany. The purchase price of approximately $136,000 was reduced by transaction costs, resulting in net proceeds of approximately $124,000. The Company recorded a realized gain on the sale of these assets of approximately $3,000 during the year ended December 31, 2012. The Company also undertook an appraisal of the remaining land and building at the Floss property and determined that no impairment charge was necessary.

 

 

 

December 31,

 

ACCRUED LIABILITIES (in thousands):

 

2013

 

 

2012

 

Components of accrued liabilities are as follows:

 

 

 

 

 

 

 

 

Payroll and benefits

 

$

1,898

 

 

$

2,326

 

Warranty accrual, current portion

 

 

1,096

 

 

 

1,699

 

Sales and excise tax

 

 

322

 

 

 

763

 

Accrued professional services

 

 

912

 

 

 

502

 

Accrued insurance premium

 

 

428

 

 

 

751

 

Other

 

 

341

 

 

 

226

 

Accrued liabilities

 

$

4,997

 

 

$

6,267

 

 

 

 

December 31,

 

DEFERRED REVENUE (in thousands):

 

2013

 

 

2012

 

Components of deferred revenue are as follows:

 

 

 

 

 

 

 

 

Undelivered elements (training, installation, product and support services)

 

$

1,823

 

 

$

1,723

 

Extended warranty contracts

 

 

1,642

 

 

 

1,506

 

Total Deferred Revenue

 

 

3,465

 

 

 

3,229

 

Less Long-Term amounts:

 

 

 

 

 

 

 

 

Extended warranty contracts

 

 

(1

)

 

 

(3

)

Total Deferred Revenue — Long Term

 

 

(1

)

 

 

(3

)

Total Deferred Revenue — Current

 

$

3,464

 

 

$

3,226

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/17/148-K/A,  DEFA14A
For Period end:12/31/1310-K/A,  SD
12/31/1210-K
8/21/124
6/12/12
 List all Filings 
↑Top
Filing Submission 0001564590-14-000856   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 4:08:34.1pm ET